© 2022 MJH Life Sciences and Modern Retina. All rights reserved.
© 2022 MJH Life Sciences™ and Modern Retina. All rights reserved.
January 11, 2022
Recent literature review reveals dearth of data, highlights need for more research.
December 27, 2021
Under terms of the agreement, ImprimisRx to assume full responsibility for US sales and marketing activities for Dexycu.
November 26, 2021
Jay Duker, MD, discusses EYP-1901, EyePoint Pharmaceuticals’ sustained-release anti-VEGF drug for the treatment of wet AMD.
November 24, 2021
Options facilitate increased durability for patients with retinal degeneration.
November 08, 2021
Dr. Timothy G. Murray discusses the 5-year follow-up data from a large, consecutive case series of combined anterior and posterior segment surgery and the benefits of a single procedure for the recovery of vision and decreased risk.
October 19, 2021
Leo Kim, MD, PhD, discusses his presentation at ASRS 2021, entitled "Rho-kinase inhibition on an in vitro patient-derived model of proliferative vitreoretinopathy."
October 07, 2021
Proposal hints at the use of generative adversarial network (GAN) for applications in macular surgery.
September 30, 2021
Pilot study shows promise of teaching surgeons with technology.
August 18, 2021
Programming includes 16 EURETINA sessions; 22 symposia; 44 instructional courses; 85 hours of content, and more than 300 speakers.
July 30, 2021
With orphan drug and fast track status, Neurotech plans to seek FDA approval for its NT-501 Implant platform late next year.